362 related articles for article (PubMed ID: 3213144)
1. [Ventricular tachyarrhythmia induced by low doses of sotalol: torsade de pointes or polymorphous ventricular tachycardia?].
Ophoff N; Toker Y
Z Kardiol; 1988 Jun; 77(6):393-7. PubMed ID: 3213144
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced torsade de pointes.
Raehl CL; Patel AK; LeRoy M
Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
[TBL] [Abstract][Full Text] [Related]
3. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
[TBL] [Abstract][Full Text] [Related]
4. Sotalol-induced prolongation of the Q-T interval and attacks of unconsciousness.
Laakso M; Pentikäinen PJ; Rehnberg S
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):487-90. PubMed ID: 6500767
[TBL] [Abstract][Full Text] [Related]
5. [Torsade de pointes ventricular tachycardia in idiopathic QT syndrome: successful treatment with AAI pacing].
Trappe HJ; Klein H; Schröder E; Siclari F; Förster K; Schlepper M; Lichtlen PR
Z Kardiol; 1988 Jun; 77(6):389-92. PubMed ID: 2463718
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the long-term effects of sotalol and atenolol on QT interval and arrhythmias after myocardial infarction.
Cobbe SM; Alexopoulos D; Winner SJ; McCaie CP; Cobbe PC; Johnston J
Eur Heart J; 1988 Jan; 9(1):24-31. PubMed ID: 2450026
[TBL] [Abstract][Full Text] [Related]
7. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
Trappe HJ; Klein H; Lichtlen PR
Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
[TBL] [Abstract][Full Text] [Related]
8. QT interval prolongation and torsade de pointes.
Patanè S; Marte F; Di Bella G
Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729
[TBL] [Abstract][Full Text] [Related]
9. [Sotalol and torsades de pointes ventricular tachycardia].
Petersen HH; Sandøe E
Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
[TBL] [Abstract][Full Text] [Related]
10. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
[TBL] [Abstract][Full Text] [Related]
11. [Suicide attempt with sotalol: a proarrhythmic intoxication].
Cherpanath TG; Geisler FE; van der Meer BJ; van Veer NE; Alings AM
Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2214-8. PubMed ID: 17969573
[TBL] [Abstract][Full Text] [Related]
12. [Iatrogenic torsade de pointes induced by thioridazine].
Paoloni P; Ciliberti D; Blasi N; Capone P
Minerva Cardioangiol; 1992 Jun; 40(6):245-9. PubMed ID: 1407620
[TBL] [Abstract][Full Text] [Related]
13. Sotalol-induced torsade de pointes.
Rakovec P; Cercek B; Rode P; Brucan A; Horvat M
Cathet Cardiovasc Diagn; 1984; 10(2):167-70. PubMed ID: 6744407
[TBL] [Abstract][Full Text] [Related]
14. [Erythrocyte-induced "torsade de pointes" ventricular tachycardia].
Lengyel C; Várkonyi T; Fazekas T
Orv Hetil; 1997 Apr; 138(16):1003-6. PubMed ID: 9153994
[TBL] [Abstract][Full Text] [Related]
15. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
[TBL] [Abstract][Full Text] [Related]
16. A case series of drug-induced long QT syndrome and Torsade de Pointes.
Tong KL; Lau YS; Teo WS
Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
[TBL] [Abstract][Full Text] [Related]
17. Sotalol-induced torsades de pointes in a patient with pre-existent normal response to programmed ventricular stimulation.
Gössinger HD; Siostrzonek P; Schmoliner R; Grimm G; Jäger U; Mösslacher H
Eur Heart J; 1987 Dec; 8(12):1351-3. PubMed ID: 3436333
[No Abstract] [Full Text] [Related]
18. [Amiodarone therapy after sotalol-induced torsade de pointes: prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects].
van de Loo A; Klingenheben T; Hohnloser SH
Z Kardiol; 1994 Dec; 83(12):887-90. PubMed ID: 7846927
[TBL] [Abstract][Full Text] [Related]
19. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.
Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ
Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
Kühlkamp V; Mermi J; Mewis C; Seipel L
J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
